{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:22:02Z","timestamp":1792120922292,"version":"4.4.0"},"reference-count":19,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"unspecified","delay-in-days":49,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>COVID-19, although a respiratory illness, has been clinically associated with non-respiratory symptoms. We conducted a negative case\u2013control study to identify the symptoms associated with SARS-CoV-2-positive results in Portugal. Twelve symptoms and signs included in the clinical notification of COVID-19 were selected as predictors, and the dependent variable was the RT-PCR test result. The <jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> tests were used to compare notified cases on sex, age group, health region and presence of comorbidities. The best-fit prediction model was selected using a backward stepwise method with an unconditional logistic regression. General and gastrointestinal symptoms were strongly associated with a positive test (<jats:italic>P<\/jats:italic> &lt; 0.001). In this sense, the inclusion of general symptoms such as myalgia, headache and fatigue, as well as diarrhoea, together with actual clinical criteria for suspected cases, already updated and included in COVID-19 case definition, can lead to increased identification of cases and represent an effective strength for transmission control.<\/jats:p>","DOI":"10.1017\/s095026882100042x","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T05:46:21Z","timestamp":1613713581000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":9,"title":["COVID-19 symptoms: a case\u2013control study, Portugal, March\u2013April 2020"],"prefix":"10.1017","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9999-8402","authenticated-orcid":false,"given":"M. Perez","family":"Duque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-9794","authenticated-orcid":false,"given":"H.","family":"Lucaccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"S\u00e1 Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"S095026882100042X_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"S095026882100042X_ref13","unstructured":"13. Portuguese Directorate-General of Health. Norma \u2013 Abordagem do Doente com Suspeita ou Infe\u00e7\u00e3o por SARS-CoV-2. Available at https:\/\/www.dgs.pt\/directrizes-da-dgs\/normas-e-circulares-normativas\/norma-n-0042020-de-23032020-pdf.aspx."},{"key":"S095026882100042X_ref11","unstructured":"11. Portuguese Directorate-General of Health. Relat\u00f3rio de Situa\u00e7\u00e3o no001, 3 de mar\u00e7o 2020 [Internet] (2020) Available at https:\/\/covid19.min-saude.pt\/wp-content\/uploads\/2020\/03\/Relat\u00f3rio-de-Situa\u00e7\u00e3o-1.pdf."},{"key":"S095026882100042X_ref9","unstructured":"9. Assembleia da Rep\u00fablica (2009) Lei n.o 81\/2009 de 21 de Agosto. Di\u00e1rio da Rep\u00fablica, pp. 5491\u20135495."},{"key":"S095026882100042X_ref15","doi-asserted-by":"publisher","DOI":"10.3390\/v10100515"},{"key":"S095026882100042X_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154262"},{"key":"S095026882100042X_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.009"},{"key":"S095026882100042X_ref12","unstructured":"12. European Centre for Disease Prevention and Control (2020) Case definition and European surveillance for COVID-19, as of 2 March 2020 [Internet]. Available at https:\/\/www.ecdc.europa.eu\/en\/case-definition-and-european-surveillance-human-infection-novel-coronavirus-2019-ncov."},{"key":"S095026882100042X_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14273"},{"key":"S095026882100042X_ref8","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000508"},{"key":"S095026882100042X_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-020-00304-9"},{"key":"S095026882100042X_ref14","unstructured":"14. European Centre for Disease Prevention and Control (2020) Case definition for coronavirus disease 2019 (COVID-19), as of 29 May 2020."},{"key":"S095026882100042X_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00038-020-01390-7"},{"key":"S095026882100042X_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102433"},{"key":"S095026882100042X_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13091"},{"key":"S095026882100042X_ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.017"},{"key":"S095026882100042X_ref10","unstructured":"10. Minist\u00e9rio da Sa\u00fade (2013) Portaria n.o 248\/2013 de 5 de agosto. Di\u00e1rio da Rep\u00fablica. 2013;1.a s\u00e9rie(N.o 149): 4624\u20134627."},{"key":"S095026882100042X_ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320926"},{"key":"S095026882100042X_ref4","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA \u2013 Journal of the American Medical Association"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026882100042X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T04:12:32Z","timestamp":1614571952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026882100042X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":19,"alternative-id":["S095026882100042X"],"URL":"https:\/\/doi.org\/10.1017\/s095026882100042x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2021. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e54"}}